Stay updated on Safety of EQ001 in aGVHD Clinical Trial
Sign up to get notified when there's something new on the Safety of EQ001 in aGVHD Clinical Trial page.

Latest updates to the Safety of EQ001 in aGVHD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history shows an addition of Revision: v3.3.3 and deletions of the HHS Vulnerability Disclosure link and Revision: v3.3.2, which are site-wide updates rather than study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new site revision entry: Revision: v3.3.2, and removed Revision: v3.3.1 from the history.SummaryDifference0.1%

- Check42 days agoChange DetectedThe revision history shows a new entry v3.3.1 added and the v3.2.0 entry removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe government funding notice banner was removed from the page, and no other content changes affecting the study record are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check63 days agoChange DetectedVersion 14 (2025-04-01) appears with updated Study Status and new sections (Outcome Measures, Participant Flow, Baseline Characteristics, Adverse Events) for the EQUATE trial history.SummaryDifference0.1%

- Check92 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference11%

Stay in the know with updates to Safety of EQ001 in aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of EQ001 in aGVHD Clinical Trial page.